New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry-Reference-Cited by-同舟云学术

New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: Insights from the all-comers, international, multicenter DELTA-2 registry

Published:2019-04 Issue: Volume:280 Page:30-37
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Tanaka Akihito^ORCID,Giustino Gennaro,Briede Ieva,Sawaya Fadi J.,Daemen Joost,Kawamoto Hiroyoshi,Meliga Emanuele,D'Ascenzo Fabrizio^ORCID,Cerrato Enrico,Stefanini Giulio G.,Capodanno Davide,Mangiameli Andrea,Templin Christian,Erglis Andrejs,Morice Marie Claude,Mehran Roxana,Van Mieghem Nicolas M.,Nakamura Sunao,De Benedictis Mauro,Pavani Marco,Varbella Ferdinando,Pisaniello Marco^ORCID,Sharma Samin K.,Tamburino Corrado,Tchetche Didier,Colombo Antonio,Chieffo Alaide

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. 2014 ESC/EACTS Guidelines on myocardial revascularization

2. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease

3. Left main coronary artery disease: secular trends in patient characteristics, treatments, and outcomes;Lee;J. Am. Coll. Cardiol.,2016

4. Percutaneous coronary intervention with drug-eluting stent versus coronary artery bypass grafting: a meta-analysis of patients with left main coronary artery disease;Spinthakis;Int. J. Cardiol.,2017

5. Meta-analysis of comparison of 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery in the era of drug-eluting stents;Khan;Am. J. Cardiol.,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contemporary use of real-world data for clinical trial conduct in the United States: a scoping review;Journal of the American Medical Informatics Association;2020-11-04

2. Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice;Medicine;2020-02

3. Does the daily risk assessment of adverse outcomes after percutaneous coronary interventions facilitate the personalized medicine approach?;International Journal of Cardiology;2019-09

4. New-generation drug-eluting stents for unselected patients with left main coronary artery disease: Crossing a second Rubicon?;International Journal of Cardiology;2019-04